Uncategorised - European Medical Journal

Real-World Data Reveals Safety Patterns of Biologics in Paediatric IBD

A large safety analysis of infliximab and adalimumab in pediatric inflammatory bowel disease highlights the need for continued postmarketing monitoring, with new concerns emerging for long-term infliximab use.

GLP-1 Receptor Agonists Show Promise in Hidradenitis Suppurativa

By Month 6 (M6), 50–60% achieved at least a one-point improvement across validated HS severity measures.

Lebrikizumab AD Experience

Experts provide real-life insights and case examples of managing moderate-to-severe atopic dermatitis, sharing their treatment experience with lebrikizumab.

NICE launches landmark guidance in type 2 diabetes

NICE unveils new type 2 diabetes guidance, promoting earlier access to advanced therapies such as SGLT-2 inhibitors and more.

Climate Changes Alter Flu Patterns After Pandemic

Pandemic-era disruptions have permanently altered the climate-influenza relationship, with new subtype-specific thresholds emerging in Southern China, according to a large-scale analysis spanning 2011 to 2024.

Long COVID: Cardiovascular Patterns Revealed with Smartwatch Biometrics

Wearables reveal unique activity and heart rate patterns in long COVID, showing promise as clinical biomarkers.

Can Power Doppler Forecast Remission in Rheumatoid Arthritis?

Power Doppler ultrasound may provide important signals in predicting treatment response for patients with rheumatoid arthritis (RA), though its ability to forecast remission remains uncertain, according to a new systematic review.

New Review Finds Oral Probiotics Improve Acne Outcomes

Oral probiotics may offer therapeutic benefits for patients with acne, according to a new systematic review and meta-analysis of randomized trials.

Pyridostigmine Boosts Recovery in Underactive Bladder Post-TURP

Taken together, the findings suggest that targeted augmentation of cholinergic signalling may help bridge the gap between anatomical de-obstruction and functional recovery in BOO-mediated UAB.

Renal Dysfunction Persists Despite Pulmonary Hypertension Treatment

A large pooled analysis shows that kidney problems are common in PAH and CTEPH, worsen survival, and see only minor improvement with current pulmonary hypertension therapies.